Century Therapeutics (IPSC) Analyst & Key Data

Analyst Consensus

Buy2 analysts

Buy

Updated Sep 12, 2026

Total Analysts2

Buy

7

Hold

2

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score1.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$1.94

Median Target+54.64%

$3.00

Potential upside vs current price

Current Stock Price

$1.94

Median Target+54.64%

$3.00

Potential upside vs current price

Analyst Consensus

Buy2 analysts

Buy

Updated Sep 12, 2026

Total Analysts2

Buy

7

Hold

2

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score1.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$1.94

Median Target+54.64%

$3.00

Potential upside vs current price

Current Stock Price

$1.94

Median Target+54.64%

$3.00

Potential upside vs current price

Century Therapeutics, Inc.